Skip to Content
COVID-19 Resources
Contact DCTD
Show menu
Search this site
Last Updated: 11/19/2021

NCI Convenes Workshop on Rational Drug Discovery

Rational Drug Discovery October 18-19, 2021 Virtual Workshop

The Developmental Therapeutics Program organized the NCI workshop on “Rational Drug Discovery” to further understand the rapidly evolving scientific and technological advancements that are shaping cancer drug discovery (October 18-19, 2021; agenda). This workshop brought together subject-matter experts from academia, industry, and federal agencies, each representing a diversity of skill sets, backgrounds, and institutions. The workshop included 18 presentations and 4 facilitated discussions in an interactive format with nearly 700 attendees.

Workshop Goals

  • Review latest developments in the fields of structural biology, novel therapeutic modalities, target interrogation, and artificial intelligence (AI) in drug discovery
  • Identify knowledge gaps, resource needs, and critical barriers in the field
  • Provide the basis for NCI to better support the extramural community and accelerate progress toward the treatment of cancer
  • Provide a forum to engage in a dialogue about discovering the next generation of cancer drugs

Workshop Sessions

  • Structural biology
  • Novel therapeutic modalities
  • Target interrogation
  • AI in drug discovery

Workshop Overview

Topic Discussion Points
Structural Biology
  • From supramolecular complexes to breakthroughs in computational software: cryogenic-electron microscopy (Cryo-EM), fragment-based drug design with Cryo-EM, drug discovery via structural biology, structure prediction and protein design, new methods for solving Cryo-EM

Novel Modalities
  • Chemical degraders (via molecular glues), covalent inhibitors, epigenetic modifiers, targeting signaling metabolites

Target Interrogation
  • Single-cell transcriptomics, CRISPR in target discovery, emerging screening approaches

AI in Drug Discovery
  • Machine Learning/AI tools in drug discovery, algorithm development to support drug discovery, considerations in using AI for drug discovery

Organizing Committee

Rose Aurigemma, PhD
Kasia Bourcier, PhD
Monica Cooper
Paul Grothaus, PhD
Rick Gussio, PhD

Tam Nguyen, PhD
Brian Peyser, PhD
Anju Singh, PhD
Sharad Verma, PhD

For more information on the workshop presentations, please contact: Kasia Bourcier (katarzyna.bourcier@nih.gov), Anju Singh (anju.singh@nih.gov), or Sharad Verma (sharad.verma@nih.gov)